A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis

Clinical trial NCT02883452 · COMPLETED

Trial details

NCT number: NCT02883452
Sponsor: Celltrion
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Crohn's Disease Ulcerative Colitis (Part 2 Only)

Start date: 2016-09-29
Primary completion: 2019-02-04
Enrollment: 181

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.